I don't believe you'll see sales in Germany, or an

I don't believe you'll see sales in Germany, or anywhere else for that matter, until the Phase 1 Safety Trial results have at least been released in a summary form. All the details might follow in a technical publication or presentation, but the company needs to state just how safe the cream has been found to be.

I frankly would also like to see the formal presentation of the preclinical efficacy data to be presented, to develop further interest in the product before sales, but that's not a mandatory presentation, safety is.

We all need to remember those psoriasis medications we've heard commercials about. I recently heard one where a couple doses needed to be taken up front, then only something like quarterly use of the drug. It all sounded good until you heard the list of side effects you might see from the medication. If you were someone lucky enough not to have those side effects, it might be a great drug for you, but some of the side effects are really severe, and I don't believe that you'll know how you'll be effected until you try the drug. I don't believe that our side effects will be serious at all, so I believe that most patient.s will choose the cream first. If the cream proves effective for them, they'll never try the drug, if not, at least they'll have tried the safer product first.

We need to remember, not everyone will benefit from ours, or other products. I believe the key to ours is that it won't have the very serious side effects that some others do. In some cases, our product could prove more effective when used in combination with others, that too is fine if the other products aren't harmful to the patient.

Gary